Featured on FierceBiotech: Lilly-partnered AbCellera gets COVID-19 boost from Canadian government

“AbCellera said it will get up to $175.6 million in support from the government of Canada under its so-called Innovation, Science and Economic Development Canada Strategic Innovation Fund. This cash boost will be used to ‘expand efforts related to the discovery of antibodies for use in drugs to treat COVID-19” as well as to build out new tech and manufacturing infrastructure for antibody therapies “against future pandemic threats.'”

Read full coverage on FierceBiotech.

PARTNERSHIP

Together we can make game-changing discoveries.